Preprint Review Version 1 This version is not peer-reviewed

Neurotensin and Its Involvement in Female Hormone-Sensitive Cancers

Version 1 : Received: 25 September 2024 / Approved: 26 September 2024 / Online: 26 September 2024 (11:33:49 CEST)

How to cite: Bertrand, N.; Mougel, R.; Riley, G.; Bruand, M.; GAUCHOTTE, G.; Agopiantz, M. Neurotensin and Its Involvement in Female Hormone-Sensitive Cancers. Preprints 2024, 2024092086. https://doi.org/10.20944/preprints202409.2086.v1 Bertrand, N.; Mougel, R.; Riley, G.; Bruand, M.; GAUCHOTTE, G.; Agopiantz, M. Neurotensin and Its Involvement in Female Hormone-Sensitive Cancers. Preprints 2024, 2024092086. https://doi.org/10.20944/preprints202409.2086.v1

Abstract

Neurotensin (NT) is a peptide involved in digestion, neuromodulation, and cancer progression. NT and its receptors (NTR1 and SORT1 mainly) have been widely studied in oncology. Data show NT expression is under the control of sex steroid hormones, in particular estradiol. We focused on its involvement in three main female hormone-sensitive cancers: breast, ovarian, and endometrial cancer in a narrative review. NT, NTR1 and SORT1 are mostly expressed in these three cancers and their involvement in oncologic processes such as proliferation and invasion seems to match, as does their impact on prognosis for most. The development of NT receptor-targeted therapies, including theranostics and radioligand treatments, presents a promising avenue for personalized cancer treatment.

Keywords

neurotensin; breast cancer; ovarian cancer; endometrial cancer

Subject

Medicine and Pharmacology, Oncology and Oncogenics

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.